Acurx Pharmaceuticals cuts stockholder meeting quorum to one-third of voting power
ACXP•Acurx Pharmaceuticals reduced the quorum for stockholder meetings from a majority to 33.33% of outstanding voting power. The board adopted the bylaw amendment effective Oct. 29, 2026, subject to exceptions under law, the certificate of incorporation or bylaws.
1. Quorum threshold reduced
Acurx Pharmaceuticals reduced its stockholder meeting quorum from a majority to one-third, or 33.33%, of outstanding voting power. The board adopted the bylaw amendment effective Oct. 29, 2026, subject to exceptions under law, the certificate of incorporation or bylaws.
